Sue J. Goldie

Roger Irving Lee Professor of Public Health
Department of Health Policy and Management
Harvard T.H. Chan School of Public Health

Director, Center for Health Decision Science
Harvard T.H. Chan School of Public Health

Director, Global Health Education and Learning Incubator at Harvard University
Special Advisor to the Provost on Global Health Education and Learning
Harvard University
Director, CHDS
Home page:
PubMed Publications

Dr. Sue J Goldie, Roger Irving Lee Professor of Public Health, is the Director of the Center for Health Decision Science (Harvard T.H. Chan School of Public Health) and Director of the Global Health Education and Learning Incubator (Harvard University).  Dr. Goldie has a secondary appointment as Professor of Global Health and Social Medicine (Harvard Medical School).  Her professional agenda includes improving women’s health in all parts of the world, using evidence-based policy to reduce global health inequities, building bridges between disciplines to tackle critical public health challenges, and fostering innovation in education.

Trained as a physician and public health scientist, she has focused her career on improving the health of vulnerable populations, in particular women, across the globe. A MacArthur award recipient (2005-2010), Dr. Goldie is renowned for rigorous scholarship and her commitment to translate new knowledge to policy. She has published close to 200 original research papers and reports, reflecting her work in mathematical disease modeling and policy analyses to guide public health decision-making. Focusing on viruses of global importance, vaccine-preventable diseases, and maternal health, she has been the Principal Investigator on awards from the National Institutes of Health, Bill & Melinda Gates Foundation, and MacArthur Foundation. She has served on several international advisory boards, including the Board on Global Health in the Institute of Medicine, and was elected to the National Academy of Sciences in 2009.

Dr. Goldie is the founding faculty director of the Harvard Global Health Institute; under her leadership, the Institute placed strong emphasis on infusing global health perspectives into educational opportunities across the University through the promotion of collaborative cross-disciplinary teaching, support of broadly inclusive learning spaces, and development of innovative pedagogical tools and approaches. Dr. Goldie is building upon and expanding this work through her leadership of the Global Health Education and Learning Incubator.

A champion of interdisciplinary education and innovative pedagogy, Dr. Goldie teaches undergraduates and graduates, and has mentored dozens of scholars and practitioners of public health. She received the Everett Mendelsohn Excel­lence in Mentoring Award from Harvard University, several Harvard Chan School Educational Awards, and Citations for Teaching Excellence in each of the last 12 years.

Dr. Goldie attended Union College (1984) and Albany Medical College (1988) during which she was elected to the Alpha Omega Alpha Honor Medical Society, and completed her residency at Yale New Haven Hospital, Yale University School of Medicine (1988-1991). She joined the Harvard School of Public Health faculty in 1998, received tenure in 2006, and was named the Roger Irving Lee Professor of Public Health in 2007. In 2011, she was appointed as the founding Faculty Director of the Harvard Global Health Institute by Harvard University President, Drew Gilpin Faust. In 2014, she was named the Director of the Global Health Education and Learning Incubator at Harvard University, and Special Advisor to the Provost on global health education and learning, by the university’s Provost Alan M. Garber.

Sue Goldie
Fall 2
An introductory course that provides a foundation for understanding health decision science methods and applications. Real world examples enrich learning about how decision science tools can be applied to important problems in clinical medicine, public health, and global health

Cost-effectiveness of Strategies to Reduce Maternal Morbidity and Mortality

There is little guidance, and few evidence based analyses, on how to cost effectively scale-up local efforts to reduce maternal mortality in the poorest countries

Cost-Effectiveness, Affordability, and Uncertainty

Even countries eligible for GAVI support for new vaccines will have to consider financial sustainability in addition to cost effectiveness

Disparities in Cancer Prevention and Control

Much of the disparity in cancer outcome is a reflection of type, timeliness, and continuity of cancer care rather than the disease itself

Global Cervical Cancer: HPV Vaccination and Diagnostics

The risk of dying from cervical cancer is unequally borne by women in developing countries

Global HIV/AIDS Policy Modeling

Identifying the most effective treatment strategies for HIV infection in less developed countries

HIV/AIDS Policy Modeling for the U.S.

Addressing critical HIV/AIDS-related clinical and policy questions within the U.S.

Prevention of Cervical Cancer in the U.S.

Informing cervical cancer prevention policy and clinical guidelines in the U.S.

ProVac: Evidence-Based Decision on New Vaccines

Collaborating to develop tools to strengthen national evidence based decisions on vaccine introduction in Latin America and the Caribbean